Gonadotropin-releasing hormone receptor expression in endometrial cancer

International Journal of Gynecological Pathology

Volumn 28, Issue 1, 2009, Pages 19-22

  Jeon, Yong Tark ^a   Kim, Yong Beom ^a   Park, So Yeon ^a   Kim, Jae Weon ^b   Park, Noh Hyun ^b   Kang, Soon Beom ^b   Song, Yong Sang ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Carcinoma; Endometrium; Gonadotropin releasing hormone receptor

Indexed keywords

GONADORELIN ANTIBODY; GONADORELIN RECEPTOR; PARAFFIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INVASION; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIPARA; OBESITY; PARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION; BIOSYNTHESIS; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PREGNANCY;

ADULT; AGED; BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PARITY; PREGNANCY; RECEPTORS, LHRH;

EID: 61449492450     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318178e54f     Document Type: Article

References (11)

1. Imai A, Tamaya T. GnRH receptor and apoptotic signaling. Vitam Horm 2000;59:1-33.
2. Grundker C, Gunthert AR, Westphalen S, et al. Biology of the gonadotropin-releasing hormone system in gynecological cancers. Eur J Endocrinol 2002;146:1-14. (Pubitemid 34126412)
3. Grundker C, Gunthert AR, Millar RP, et al. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 2002;87:1427-1430 (Pubitemid 36121120)
4. Volker P, Grundker C, Schmidt O, et al. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. Am J Obstet Gynecol 2002;186:171-179 (Pubitemid 34165428)
5. Jeon YT, Park IA, Kim YB, et al. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication. Cancer Lett 2006;239:198-204.
6. Jeon YT, Kang S, Kang DH, et al. Cyclooxygenase-2 and p53 expressions in endometrial cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1538-1542 (Pubitemid 39202324)
7. Jeon YT, Park SY, Kim YB, et al. Aromatase expression was not detected by immunohistochemistry in endometrial cancer. Ann N Y Acad Sci 2007;1095:70-75
8. Marelli MM, Moretti RM, Januszkiewicz-Caulier J, et al. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? Curr Cancer Drug Targets 2006;6:257-269
9. Harrison GS, Wierman ME, Nett TM, et al. Gonadotropinreleasing hormone and its receptor in normal and malignant cells. Endocr Relat Cancer 2004;11:725-748 (Pubitemid 40065547)
10. Yue Y, Piao JX, Wang LN, et al. Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus. Zhonghua Fu Chan Ke Za Zhi 2006;41:326-328
11. Shiozawa T, Konishi I. Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment. Int J Clin Oncol 2006;11:13-21. (Pubitemid 43320322)